NASDAQ:AVR Anteris Technologies Global Q3 2026 Earnings Results & Report $5.06 -0.16 (-2.98%) As of 02:47 PM Eastern This is a fair market value price provided by Massive. Learn more. Anteris Technologies Global beat analyst earnings expectations but missed on revenue in its Q3 2026 results, released November 10, 2026. The company reported EPS of -$0.28 versus the -$0.3114 consensus estimate, while revenue of $519 thousand fell short of the $2.75 million estimate by $2.23 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 10, 2026TimeAfter Market ClosesConference Call DateNovember 9, 2026Conference Call6:00 PM ET Anteris Technologies Global EPS ResultsActual EPS-$0.28Consensus EPS -$0.3114Beat/MissBeat by +$0.0314One Year Ago EPSN/AEPS Beat Rate1 of last 5 quartersAnteris Technologies Global Revenue ResultsActual Revenue$519 thousandExpected Revenue$2.75 millionBeat/MissMissed by -$2.23 millionYoY Revenue GrowthN/AConference Call ResourcesPress ReleaseQuarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress ReleaseQuarterly report(10-Q) Anteris Technologies Global Q3 2026 Earnings FAQ Did Anteris Technologies Global beat earnings estimates for Q3 2026? Anteris Technologies Global (NASDAQ:AVR) reported earnings of -$0.28 per share for Q3 2026, beating the consensus estimate of -$0.3114. The report was announced on Tuesday, November 10, 2026. What was Anteris Technologies Global's revenue for Q3 2026? Anteris Technologies Global reported revenue of $519 thousand for Q3 2026, against a consensus estimate of $2.75 million. Anteris Technologies Global Earnings HeadlinesAnteris Announces Late-Breaking PCR London Valves Data Release: One-Year DurAVR THV Outcomes in 100 PatientsNovember 16 at 6:00 AM | globenewswire.comAnteris Technologies Global (NASDAQ:AVR) Stock Gets Price Target Trim from BarclaysNovember 16 at 2:18 AM | americanbankingnews.comMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.November 19 at 1:00 AM | Profits Run (Ad)Anteris Technologies Global (NASDAQ:AVR) Stock Falls 7.5% After Analyst DowngradeNovember 15, 2026 | americanbankingnews.comCantor Fitzgerald Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)November 14, 2026 | theglobeandmail.comAnteris Technologies Q3 Loss Narrows, Net Sales UpNovember 11, 2026 | marketscreener.comMSee More Anteris Technologies Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email. Email Address About Anteris Technologies GlobalAnteris Technologies Global (NASDAQ:AVR) is a medical technology company focused on developing treatments for structural heart disease, particularly aortic valve conditions. Its work centers on transcatheter heart valve technology, which is designed to replace a damaged valve through a minimally invasive procedure. The company’s lead product is the DurAVR transcatheter heart valve. It is made using Anteris’ ADAPT tissue technology, which processes bovine pericardial tissue for use in medical devices. The valve is designed to resemble the structure and function of a healthy aortic valve. Anteris has roots in Australia and serves the global medical device market. Its activities include developing and evaluating its heart valve technology for potential use by clinicians treating patients with aortic valve disease.View Anteris Technologies Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.